Hear candid conversations between people conquering cancer – patients, their family and friends, and doctors and researchers working to help us all.
A Miracle Mix of Chemotherapy Cures Testicular Cancer
In 1974, men diagnosed with testicular cancer faced an overall survival rate of 5 percent. Surgery was the only viable treatment option, and if it failed, the prognosis was fatal.
Dr. Einhorn was a young medical oncologist at Indiana University Hospital. He was the first to test a chemotherapy combination in a landmark clinical trial that led to a cure for testicular cancer. Dr. Einhorn continued working on the treatment to find new ways to minimize toxic side effects and shorten the treatment.
Following the discovery, the cure rate for metastatic cases went to 80 percent. Today, Cancer.Net reports the general five year survival rate for men is 95 percent.
Dr. Einhnorn talks to his friend and colleague, Patrick Loehrer, MD, about how he outsmarted what was once the deadliest form of male cancer.
